 Innate Pharma S.A. NASDAQ:IPHA First Half 2022 Financial Results and Business Update September 15, 2022 8:00 AM ET Company Participants Henry Wheeler Investor Relations Mondher Mahjoubi Chief Executive Officer Joyson Karakunnel Executive Vice President and Chief Medical Officer Yannis Morel Executive Vice President-Business Development and Product Portfolio Strategy Frédéric Lombard Chief Financial Officer Conference Call Participants Carly Kenselaar Citi Daina Graybosch SVB Securities Nick Hallatt Goldman Sachs Olga Smolentseva Bryan Garnier Henry Wheeler Good morning and good afternoon and welcome everybody. 